Loading asset research
Ernexa Therapeutics Inc. Common Stock
ERNANasdaq · USD · StocksQuote as of · Exchange session not verified$4.17
+3.73%
Today
ERNA
Loading 1D prices…
Market cap
$4.9M
Volume
19.8K
52w high
$71.5052w low
$3.18Company profile
Ernexa Therapeutics Inc. Common Stock
Ernexa Therapeutics Inc., a preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of treatment of cancer and autoimmune disease. The company's lead product is ERNA-101, an allogenic pro-inflammatory cytokine (IL-7/IL-15) secreting iMSC for the treatment of ovarian cancer; and ERNA-201, an anti-inflammatory cytokine (IL-10) secreting iMSC for the treatment of rheumatoid arthritis. It has a license agreement with Factor Bioscience Limited. The company was formerly known as Eterna Therapeutics Inc. and changed its name to Ernexa Therapeutics in March 2025. Ernexa Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Cambridge, MA, United States
Employees
5
Fiscal year end
1231
CIK
748592
Session & valuation
Open$4.05
Previous close$4.02
Day high$4.42
Day low$4.03
30-day avg. volume36.3K
Outstanding shares1.6M
Diluted EPS-$2.24
Latest annual period
P/E (trailing)-1.86
P/E (forward)-0.43
Price / book1.52
Beta2.62
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| GLMDGalmed Pharmaceuticals Ltd. Ordinary Shares | $4.9M | $0.00 | — | $2.39 | -4.71% | Hold |
| CANFCan-Fite Biopharma Ltd American Depositary Shares each representing two (2) Ordinary Shares | $5M | $405K | -2426.67% | -$5.97 | +9.72% | Buy |
| PULMPulmatrix Inc. Common Stock | $5.1M | $0.00 | — | -$1.41 | -3.42% | Unrated |
| LABTLakewood-Amedex Biotherapeutics Inc. Common Stock | $5.3M | $0.00 | — | -$2.76 | +8.29% | Unrated |
| ADXNAddex Therapeutics Ltd American Depositary Shares | $4.4M | — | — | -$7.20 | +2.95% | Unrated |